A Deep Learning Method For Predicting Patient Response To A Therapy

Patent №

US 11,348,231

Granted

2022-05-31

Filed 2019

Owner

DEFINIENS GMBH

+1 more

Lab

AI components

4

ml · vision · planning · hardware

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

16705238

A method for indicating how a cancer patient will respond to a predetermined therapy relies on spatial statistical analysis of classes of cell centers in a digital image of tissue of the cancer patient. The cell centers are detected in the image of stained tissue of the cancer patient. For each cell center, an image patch that includes the cell center is extracted from the image. A feature vector is generated based on each image patch using a convolutional neural network. A class is assigned to each cell center based on the feature vector associated with each cell center. A score is computed for the image of tissue by performing spatial statistical analysis based on classes of the cell centers. The score indicates how the cancer patient will respond to the predetermined therapy. The predetermined therapy is recommended to the patient if the score is larger than a predetermined threshold.

Machine learningVisionPlanningAI hardwareG06V 10/82G01N 1/30G06F 18/2414G06T 7/0012G06T 7/136G06T 7/337G06T 7/35G06V 10/764+7 more

AI classification

Vision1.00
Machine learning1.00
Planning0.95
AI hardware0.93
Knowledge representation0.01
Evolutionary computation0.00
Speech0.00
Natural language0.00

Ownership

DEFINIENS GMBH

assignment · 511970295

ASTRAZENECA COMPUTATIONAL PATHOLOGY GMBH

namechg · 588600136

Assignors

SCHMIDT, GUENTER, BRIEU, NICOLAS, KAPIL, ANSH, LESNIAK, JAN MARTIN

On an employer assignment, the assignors are typically the inventors.

From the same owner

© 2026 NYSGPT2525 LLC